$LPCN - FDA Accepts for Filing Lipocine’s New Drug Application for Its Oral Testosterone Replacement Product Candidate, LPCN 1021 http://www.nasdaq.com/press-release/fda-accepts-for-filing-lipocines-new-drug-application-for-its-oral-testosterone-replacement-produc-20151029-01448#ixzz3q3rgYf2s